ICE BEARING two mutant alleles at either the M Dominant White Spotting (W) or Steel (SI) loci have identical phenotypes of hypopigmentation, sterility, and a severe macrocytic anemia.' Bone marrow (BM) transplantation studies have shown that the defect in W mice is intrinsic to primitive hematopoietic stem cells, while the defect in SI mice is intrinsic to the hematopoietic microenvironment.'" Recent studies have shown that mutations in the c-kit proto-oncogene, a member of the tryosine kinase growth factor receptor family, are responsible for the Wmutations.4-8 The ligand for the c-kit gene product has been shown to be a novel hematopoietic growth factor designated stem cell factor (SCF; also referred to as mast cell growth factor [MGF] , or kit ligand [JSL]).9-'6 Mutations in the SCF gene are responsible for the SI In combination with other growth factors, particularly interleukin-3 (IL-3) or IL-6, SCF has been shown to support the growth of hematopoietic colony-forming cells.10.12.15 Specifically, SCF has been shown to be an enhancer of erythropoietin-dependent mixed colony and burst-forming unit-erythroid (BFU-e) formation. In addition, SCF in combination with IL-3, granulocyte-macrophage colony-stimulating factor (GM-CSF), or granulocyte colony-stimulating factor (G-CSF) increases both the number and size of mixed colonies, BFU-e, colony-forming unit-granulocyte-macrophage (CFU-GM), and colonyforming unit-granulocyte (CFU-G), respe~tively.~~ The combination of SCF with IL-6 decreases the time of appearance of multipotential blast cell colonies, similar to the effects of IL-3 and IL-6 on the same cells. 20 Using purified BM cells in culture, SCF had been shown to increase colony-forming unit-spleen (CFU-S) numbers in combination with IL-3 and IL-1cy.2'
Prior work in our laboratory has established assays for defining the effects of growth factors on primitive hematopoietic cells. We have used a modified CFU-S assay to show that CFU-S can be maintained in populations of BM cells cultured in IL-3. The addition of IL-6 to cultures containing IL-3 increased CFU-S number eightfold. This increase in CFU-S number was accompanied by an increase in the number of cycling cells and by an increase in the frequency of infection by retroviruses. Using a competitive repopulation assay, we have shown that the long-term repopulating the number at day 0. The long-term repopulating ability of cells cultured in SCF, IL-3, and IL-6 was approximately sevenfold better than that of cells cultured in IL-3 or SCF. Similar experiments were performed on populations of bone marrow cells enriched for, or depleted of, CFU-S by elutriation and lineage subtraction. The combination of SCF and IL-6 increased CFU-S number approximately fourfold t o eightfold in the CFU-S-enriched fraction, but had no effect on the CFU-S-depleted cells. These results show that SCF alone can increase CFU-S number in vivo, and in combination with other growth factors increases CFU-S numbers in vitro.
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ability of BM cultured in the combination of IL-3 and IL-6 was approximately twofold greater than that of marrow cultured in IL-3 alone. The increased repopulating ability was likewise accompanied by an increased frequency of retrovirus Because of the association of SCF with the W and SI mutations, and the potent effects of SCF on hematopoietic colony formation, we tested the effects of SCF in vitro in the CFU-S and competitive repopulation assays and by in vivo administration. Our results show that SCF administration to S1/Sld mice increases CFU-S numbers up to 20-fold in vivo. In vitro, SCF in combination with either IL-6 or IL-3 and IL-6 increases CFU-S number and, to a smaller extent, long-term repopulating ability. In experiments using populations of cells enriched or depleted of CFU-S, increased numbers of CFU-S in the presence of SCF and IL-6 was only observed in cultures of cells enriched for CFU-S. These results suggest that the additional CFU-S are derived from existing CFU-S.
MATERIALS AND METHODS
Mice. All mice were purchased from the Jackson Laboratory (Bar Harbor, ME). In most experiments, donor mice were treated with 150 mglkg 5-fluorouracil (5-FU) (Fluka, Ronkonkoma, NY) 48 hours before BM harvest?s The donor animals for the CFU-S experiments were C57BL/6J, and the recipient animals were WBB6F1-+ I+. The donor animals for the competitive repopulation assays were either C57BLl6J or B6.C-Hlb/By (designated HW80), and the recipient animals were WBB6Fl-WIW. The donor animals for experiments involving the in vivo administration 914 BODINE ET AL of SCF were WCB6F1 SI/Sld. These animals were injected subcutaneously with 100 kg/kg/d rat SCF modified by the addition of poly-ethylene glycol" for 21 days. Control mice were injected with vehicle alone. BM and spleen cells were harvested for injection at day 21. The recipient animals for these experiments were WCB6F1-+/+.
The CFU-S assays were performed as described% with the modification that the cells were cultured in Corning (Corning, NY) suspension culture dishes for 6 days before injection into irradiated (900 rad) recipients.u Using these conditions, no CFU-S are observed in uninjected mice. Spleens were harvested 12 to 14 days after transplantation and fixed in Telly's fixative (70% E t O H acetic acid:formalin; 201:l) and the number of macroscopic colonies on each spleen was determined. The data in Tables 1 and 2 are expressed as the mean number of CFU-S per 105 cells injected (rt standard deviation), and was derived from at least 40 CFU-S colonies located on at least 10 spleens. Two separate experiments were performed with unfractionated BM cells ( Table 2 ) and with purified BM cells (see Table 5 ).
The competitive repopulation assays were performed as described" with the modification that the cells were maintained in liquid suspension culture for 6 days before Table 3 ).
BM cells from untreated C57BL/6J donors was separated by elutriation using a Beckman (Columbia, MD) JE-6B elutriator system at 3,000 rpm exactly as de~cribed.'~ After loading at a flow rate of 15 mL/min, cells were eluted stepwise at 25 mL/min (FR 25), 29 mL/min (discarded), and 35 mL/min (FR 35). The FR 25 and FR 35 fractions were mixed with a cocktail of fluorescein isothiocyanate (FITC)-conjugated monoclonal antibodies to CD4, CD8, B220, Mac-1, and GR-1 (all from Caltag Laboratories Inc, San Francisco, CA). After the addition of magnetic beads coated with goat anti-FITC antibodies (Advanced Magnetics, Cambridge, MA), lineagepositive cells were removed by two passes through a Biomag separator (Advanced magnetic^).^" Analysis of the purified FR 25
Lin-and FR 35 Lin-populations showed that fewer than 1% to 3% of the remaining cells were positive for the lineage markers.
Unfractionated or purified BM cells were maintained in suspension culture dishes in Dulbecco's CFU-S assays.
Competitive repopulation assays.
Stem cell and CFU-S purification.
Cell culture and growth factors. modified Eagle's medium (DMEM), 15% fetal calf serum (Hyclone, Logan, UT), 4 mmol/L glutamine, 50 mg/mL penicillin G, and 50 U/mL streptomycin, as described?"" Cell density was maintained at 5 x 105 cells/mL. In some cases, this required the addition of medium during the experiment. Murine IL-3, human IL-6, and rat SCF were produced by Escherichia coli and purified at Amgen Corporation (Thousand Oaks, CA). Murine IL-3 was used at a concentration of 200 U/mL. Human IL-6 and rat SCF were used at a concentration of 100 ng/mL.
RESULTS
It was shown previously that the administration of SCF to Sl/Sld animals resulted in a partial correction of the severe macrocytic anemia as well as the reconstitution of mast cells at the injection site." In vivo administration of rat SCF to S1/Sld animals for 21 days resulted in a twofold increase in CFU-S number in BM, which is largely due to increased BM cellularity (Table 1 ). There was no increase in spleen cellularity in the treated animals, but the number of CFU-S in the spleen increased 20-fold (Table 1 ). This experiment was performed twice with identical results.
Effects of SCF on CFU-S number in unfractionated BM cells cultured in vitro.
Because SCF was shown to increase CFU-S numbers in vivo, the effects of SCF on CFU-S number in liquid suspension culture were examined. After 6 days of suspension culture, no CFU-S survived in the absence of growth factor (Table 2) . Low numbers of CFU-S survived in the presence of purified recombinant IL-3 or SCF alone. BM cells cultured in the presence of two factors (IL-3 and purified recombinant IL-6, or IL-3 and SCF) contained approximately eightfold more CFU-S than cells cultured in either IL-3 or SCF alone (P < .001). The largest increases in CFU-S number was observed in BM cells cultured in the combination of IL-6 and SCF, or in all three factors (IL-3, IL-6, and SCF). These cultures contained 15-to 20-fold more CFU-S/lOS cells than cells cultured in a single growth factor (P < .001), and the total number of CFU-S in these cultures was twofold to threefold greater than the number of CFU-S in these cultures at day 0 ( Table 2) .
Effects of SCF on long-and short-term repopulating ability in unfractionated BM cells cultured in vitro. The effect of SCF on the short-and long-term repopulating ability of cultured cells was analyzed in a competitive repopulation assay 35 and 120 days posttransplantation, respectively. In this assay, the percentage of single and diffuse Hb in the peripheral blood of reconstituted recipients reflects the relative contributions of genetically marked long-term repopulating stem cells to the erythroid compartment. Other groups and ourselves have shown that stem cells with short-term repopulating ability rather than long-term repopulating ability contribute the majority of circulating cells early in the reconstitution period, while long-term reconstitution is complete by 120
The short-term repopulating ability (as measured 35 days posttransplantation) of C57BL/6 BM cells cultured in the absence of growth factor was threefold less than that of HW80 cells cultured in either IL-3 alone or in SCF alone (Fig 1; P < Numbers of CFU-S in uncultured BM (day 0) in experiments 1 and 2 were 11.2 f 5.1 CFU-S/106 cells* and 14.2 & 6.0 CFU-S/I05 cells,* respectively. *With the exception of no growth factor, each data point represents at least 39 CFU-S colonies distributed among at least 10 spleens.' t P < .001 relative to IL-3. SP < .001 relative to SCF.
had similar short-term repopulating ability. C57BL/6 BM cells cultured in the combinations of two factors (IL-3 and IL-6, IL-3 and SCF, or IL-6 and SCF) or all three factors (IL-3, IL-6, and SCF) had fourfold more short-term repopulating ability than HW80 BM cells cultured in IL-3 alone (Fig I; P < .001) . By comparison, the short-term repopulating ability of these two-and three-factor combinations were equally superior to the short-term repopulating ability of cells cultured in SCF alone.
In the long-term competitive repopulation assay (I25 days), the relative contributions of C57BL/6 and HW80 BM cultured in IL-3 form a baseline for comparison with other conditions. In experiment 1 (Fig 2 and Table 4) , the C57BL/6 and HW80 cells contributed equivalent numbers of circulating cells. In experiment 2 (Tables 3 and 4) , the C57BL/6 BM cells contributed 1.6-fold more circulating erythroid cells than the HW80 cells, establishing a higher baseline. Reconstitution by donor cells was shown by analysis of Pep-3 isozyme." All recipient mice were homozygous a/a like the donor strains, not heterozygous a/b like untransplanted W / W recipients (data not shown). C57BL/6 NO 11-3 11-3 11-3 SCF IL-3 SCF 11-3 11-3 11-3 SCFIL-3 SCF 11-3 GF 11-3
11-6
11-6 11-3 Table 3 ; P < .001). When the relative repopulating ability is corrected for the number of cell recovered from the cultures, the overall repopulating ability of cells cultured in the combination of all three factors (SCF, IL-3, and IL-6) was sevenfold greater than that of cells cultured in IL-3 alone (Table 4) . In contrast to the CFU-S and short-term competitive repopulation assays, C57BL/6 BM cells cultured in the presence of IL-6 and SCF contributed similar numbers of circulating erythroid cells as HW80 cells cultured in IL-3 only (Fig 2 and Table 3 ). However, when the relative repopulating ability is corrected for the number of cells recovered from the cultures, the overall repopulating ability of cells cultured in the combination of SCF and IL-6 showed a modest and variable increase (Table 4) . These observations were extended to nucleated hematopoietic cells by Southern blot analysis of DNA extracted from the hematopoietic tissues of long-term competitive repopulation assay recipients. The DNA was digested with EcoRI and probed with a mouse P-globin probe. Analysis of DNA froh C57BL/6 mice showed two bands of 10 kb, while DNA from HW80 mice showed a faint band of 14 kb (Bminor) and a dark band of 7 kbM (BmaJ"; lanes 1 through 3 in Fig 3A  and B) . DNA extracted from the BM and thymus of competitive repopulation recipients of C57BL/6 cells cultured in the absence of growth factor and HW80 cells cultured in IL-3 contained only the 7-and 14-kb bands of the HW80 donor (lanes 4,5, and 2, respectively; Fig 3A and  B) . DNA extracted from the BM and thymus of competitive repopulation recipients of C57BL/6 cells cultured in IL-3 and HW80 cells cultured in IL-3 contained the 7-, lo-, and 14-kb bands, similar to the pattern observed in an animal heterozygous for single and diffuse Hb (lanes 6, 7, and 3, respectively; Fig 3A and B) . DNA extracted from the BM and thymus of competitive repopulation recipients of C57BL/6 cells cultured in the combination of IL-3, IL-6, and SCF and HW80 cells cultured in IL-3 contained primarily the 10-kb bands of the C57BL/6 haplotype (lanes 8,9, and 1, respectively; Fig 3A and Table 3 .
For 
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--c and whether the effect was on existing CFU-S or a pre-CFU-S cell, these experiments were repeated using purified populations of hematopoietic cells. Jones et al showed that CFU-S could be separated from long-term repopulating stem cells by elutriation,*g with the low-density fraction (FR 25) containing long-term repopulating cells, but depleted of CFU-S, and higher density fractions containing CFU-S. Cells from C57BL/6 mice were eluted at 25 mL/min (FR 25), 29 mL/min (discarded), and 35 mL/min (FR 35; contains CFU-S). We further purified these populations by removing cells expressing lineage- tCFU-S numbers derived from one spleen each in this experiment.
For personal use only. on October 3, 2017. by guest www.bloodjournal.org From alone or the combination of SCF and IL-6. The low number of CFU-S in the FR 25 Lin-cells declined further after 6 days of culture in either SCF alone or in the combination of SCF and IL-6 (Table 5) . Similarly, there was a twofold to fivefold reduction in the number of CFU-S in the FR 35 Lin-cells cultured in the presence of SCF alone. Extensive cell proliferation was observed in FR 35 Lin-cells cultured in the combination of SCF and IL-6. After culture, these cells contained 45 to 80 CFU-S/l@ cells, which was sixfold to sevenfold greater than the number of CFU-S in FR 35 Lin-cells cultured in SCF alone (Table 5 ). The overall number of CFU-S in these cultures increased fourfold to eightfold over the starting number. The magnitude of this increase is greater than that seen in unfractionated cells cultured in the same growth factors.
DISCUSSION
We have used the CFU-S assay and the competitive repopulation assay to determine the effects of SCF on primitive hematopoietic cells in vivo and in vitro. We have previously shown that in the presence of IL-3 and IL-6, CFU-S number in liquid suspension culture declines during the first 48 hours of culture, followed by an increase in CFU-S number that is associated with an increase in cell cycling and an increase in retrovirus infection. 2224 In the experiments presented here we have used highly purified recombinant IL-3 and IL-6. Our results using these factors were identical to our previous studies using IL-3 and IL-6 in the form of COS cell conditioned medium."."
Administration of SCF alone to SIISld mice in vivo caused an increase in CFU-S numbers. In vitro, however, CFU-S numbers and short-term repopulating ability were only increased relative to the amount in the culture at day 0 when SCF was supplied with IL-6 (with or without IL-3). Based on these results, we propose that the exogenously supplied SCF interacts with endogenous growth factors to produce the increase in CFU-S number observed in SIISld mice.
In a previous study, we showed that of the 12 interleukins or colony-stimulating factors tested, only IL-3 could support long-term repopulating stem cells in vitro as a single factor. In this study, we have shown that limited numbers of long-term repopulating stem cells survive in the presence of SCF as we1LZ4 These results indicate that primitive hematopoietic progenitor cells require either SCF or IL-3 to prevent apoptosis. The overall long-term repopulating ability of cells cultured in the presence of SCF, IL-3, and IL-6 is approximately threefold greater than the repopulating ability of cells cultured in any combination of two factors (IL-3 and IL-6, IL-3 and SCF, or SCF and IL-6). We have shown previously that cells cultured for 6 days in IL-3 and IL-6 have -80% the repopulating ability of uncultured BM cells. We infer that the overall repopulating ability of cells cultured in the combination of SCF, IL-3, and IL-6 is increased approximately twofold relative to uncultured BM. Our results indicate that the combination of SCF, IL-3, and IL-6 increases the number of CFU-S in vitro to a greater degree than we observed for long-term repopulating stem cells.
de Vries et al2' have examined the effects of SCF (MGF) on populations of BM cells enriched for primitive hematopoietic stem cells by low-density centrifugation followed by selecting wheat germ-positive, 15-1.41-negative cells and dividing these cells into rhodamine-bright and -dull populations. They found that CFU-S number was increased in the presence of SCF and IL-3, and to a smaller degree by the combination of SCF and IL-la. The magnitude of this response was greater in the rhodamine-bright cells than in the rhodamine-dull cells. These results are complementary to our observation that SCF and IL-6 increases the number of CFU-S in populations of lineage marker-negative BM cells already containing CFU-S (FR 35 Lin-), but not in populations of cells containing long-term repopulating cells but depleted of CFU-S (FR 25 Lin-). These data indicate that the increase in CFU-S number in response to the combination of SCF and IL-6 was due to the proliferation of existing CFU-S rather than the "recruitment" of CFU-S from the repopulating stem cell pool.
Our experiments used SCF as a soluble protein. In vivo, SCF exists as both a soluble form and as a membraneassociated molecule on BM marrow stromal cell^.'^^'^^^^^'^ The SldISld mouse produces only the soluble form of SCF, as an internal deletion has removed the membrane spanning domain of the molecule (K.M. Zsebo et al, unpublished observations).'8 SCF generated from the Sld gene has equivalent biologic effects as soluble wild-type SCF in vitro (K.M. Zsebo et al, unpublished observations),'8 but Sld/Sld mice have a severe macrocytic anemia as well as hypopigmentation and sterility.' These findings suggest that membrane-associated SCF might be more active on pluripotent hematopoietic stem cells.
